Cervical Polyp Before IVF: Does It Need Removal Before Embryo Transfer?

A cervical polyp is generally seen at the cervix during speculum examination. An endometrial polyp is an intrauterine finding often assessed with ultrasound or saline infusion imaging. Imaging reports may use unfamiliar terminology, so ask the clinician to draw or explain the lesion's position. A polyp outside the cavity is not necessarily a reason for embryo implantation to fail; a finding in the uterine cavity may merit a different discussion. Size, bleeding, surface appearance and previous cervical screening history can guide examination and whether tissue should be sent for pathology.

Spotting after intercourse or between periods, unusual discharge, and a visible lesion are reasons to seek assessment rather than treating the fertility schedule as the only issue. A clinician may recommend examination or biopsy if there are atypical features. Not all bleeding is from a polyp: infection, pregnancy, cervical changes or uterine problems may need consideration. For someone preparing for frozen embryo transfer, active unexplained bleeding should be reported before starting or adjusting hormones. Remote advice can triage questions, but diagnosis often requires a physical examination.

Embryo transfer requires a clinician to pass a thin catheter through the cervical canal into the uterus. A lesion that obstructs the passage or bleeds with manipulation may affect practical planning. However, the presence of a small cervical polyp does not establish that transfer will be difficult. If the previous procedure involved significant cervical difficulty, ask whether a preparatory examination or alternate catheter plan is warranted. There is no need to assume a new add-on or surgery is helpful without evidence of a specific problem.

Options depend on whether the lesion is symptomatic, persistently bleeding, suspicious on examination or mechanically problematic. Removal may be straightforward in some circumstances, but the operator must consider infection risk, bleeding, pathology and appropriate timing relative to fertility treatment. The specimen may be sent for histopathology. Do not attempt removal at home or accept unverified therapies intended to 'shrink' a lesion before transfer. It is reasonable to ask whether a proposed delay is necessary for healing or results and how the decision would change if pathology is benign.

A cervical finding alone cannot predict egg quality, embryo chromosome status or live birth. Conversely, a normal cervix does not rule out a uterine-cavity problem. If repeated transfer failures prompted the investigation, a comprehensive review may also consider embryo information, uterine imaging and medication timing rather than attributing everything to a visible polyp. The aim is a documented reason for every intervention. A second opinion can be useful when the imaging wording and physical examination disagree or surgery is proposed without a clear indication.

HomeIVF and the limits of home-supported IVF. HomeIVF describes doctor-led fertility care that can coordinate treatment discussions and, when actually available and clinically suitable, selected home blood collection, injection assistance or teleconsultations. The purpose is fewer unnecessary clinic visits, not moving the IVF laboratory into the home. Follicle and lining scans may require visits to an imaging facility; egg retrieval, sperm preparation and embryology work, and embryo transfer remain facility-based. Even a familiar medicine or blood test may not be safe or appropriate for home delivery in every case. Availability, technique, timing and escalation routes must be checked with the responsible clinician before a cycle begins.

HomeIVF can support a doctor-led review of an existing examination report and coordinate questions before a procedure. A teleconsultation cannot confirm the appearance of an unexpected cervical lesion without examination. Imaging, polyp removal, pathology sampling and embryo transfer require appropriate medical facilities. Where feasible, selected tests may be coordinated close to home, but a procedural visit cannot be replaced by an injection-support arrangement.

Turn information into an individual plan. Ask the treating fertility specialist to separate confirmed findings from possibilities, and to specify which result would genuinely change the next decision. Request an itemised written estimate that distinguishes consultation, stimulation medicines, ultrasound monitoring, laboratory handling, anaesthesia, egg retrieval, freezing, storage, testing and transfer where applicable. Not every item is needed in every cycle; some are optional, and prices should not be assumed from a national headline. Record the emergency contact pathway, the next appointment and any symptoms that call for urgent in-person assessment. This avoids mistaking remote convenience for reduced clinical oversight.

Ask whether the polyp is cervical, uterine, or both; whether it causes symptoms; and whether it could obstruct the intended catheter path. Request a written plan for examination, pathology when indicated and the timing of any treatment. Clarify separate fees for scan, office procedure, anaesthesia if needed and transfer rescheduling. Do not pay for a procedure simply because a package includes a 'polyp clearance' step. The decision should rest on an actual documented finding.